Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $50.2 million versus the consensus estimate of $49.66 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.